[4-Oxo-4-(phenylmethoxyamino)butyl]phosphonic acid | 1376377-44-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: [4-Oxo-4-(phenylmethoxyamino)butyl]phosphonic acid
• CAS: 1376377-44-4
• 化学式: C₁₁H₁₆NO₅P
• 分子量: 273.226
• InChiKey: JLEHWJYFVCMABQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.5
• 重原子数：
  18
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  95.9
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  特戊酸氯甲酯 、 [4-Oxo-4-(phenylmethoxyamino)butyl]phosphonic acid 在 三乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 0.08h， 以66 mg的产率得到di(pivaloyloxymethyl) 4-(benzyloxyamino)-4-oxobutylphosphonate
  参考文献：
  名称：

  Growth inhibition of Mycobacterium smegmatis by prodrugs of deoxyxylulose phosphate reducto-isomerase inhibitors, promising anti-mycobacterial agents

  摘要：

  Since Mycobacterium tuberculosis sets up several multiple anti-tuberculosis drug resistance mechanisms, development of new drugs with innovative target is urgent. The methylerythritol phosphate pathway (MEP) involved in the biosynthesis of essential metabolites for the survival of mycobacteria, represents such a target. Fosmidomycin la and FR900098 1b, two inhibitors of DXR, do not affect the viability of M. tuberculosis cells, due to a lack of uptake. To overcome the absence of the mycobacterial cell wall crossing of these compounds, we synthesized and tested the inhibition potency of acyloxymethyl phosphonate esters as prodrugs of fosmidomycin la, FR900098 1b and their analogs 2a and 2b on Mycobacterium smegmatis. Only the prodrugs 4b-6b inhibit the bacterial growth and could be effective antimycobacterial agents. (C) 2012 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2012.02.031
• 作为产物：
  描述：

  diethyl 4-(benzyloxyamino)-4-oxobutylphosphonate 在 三甲基溴硅烷 、 水 作用下， 以 二氯甲烷 为溶剂， 反应 0.08h， 生成 [4-Oxo-4-(phenylmethoxyamino)butyl]phosphonic acid
  参考文献：
  名称：

  Growth inhibition of Mycobacterium smegmatis by prodrugs of deoxyxylulose phosphate reducto-isomerase inhibitors, promising anti-mycobacterial agents

  摘要：

  Since Mycobacterium tuberculosis sets up several multiple anti-tuberculosis drug resistance mechanisms, development of new drugs with innovative target is urgent. The methylerythritol phosphate pathway (MEP) involved in the biosynthesis of essential metabolites for the survival of mycobacteria, represents such a target. Fosmidomycin la and FR900098 1b, two inhibitors of DXR, do not affect the viability of M. tuberculosis cells, due to a lack of uptake. To overcome the absence of the mycobacterial cell wall crossing of these compounds, we synthesized and tested the inhibition potency of acyloxymethyl phosphonate esters as prodrugs of fosmidomycin la, FR900098 1b and their analogs 2a and 2b on Mycobacterium smegmatis. Only the prodrugs 4b-6b inhibit the bacterial growth and could be effective antimycobacterial agents. (C) 2012 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2012.02.031